Potent P2Y12 Inhibitors vs Clopidogrel in Cancer Patients Undergoing Percutaneous Coronary Intervention
Canadian Journal of Cardiology · 2025
DOI: 10.1016/j.cjca.2025.02.035 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Canadian Journal of Cardiology, 2025. Verfasst von Mauro Gitto und 16 weiteren Autor:innen. Beteiligte Einrichtung: Mount Sinai Fuster Heart Hospital, Icahn School of Medicine at Mount Sinai, New York, New York, USA; Department of Biomedical Sciences, Humanitas Uni…. Hauptthemen laut MEDLINE: Purinergic P2Y Receptor Antagonists, Percutaneous Coronary Intervention, Neoplasms, Ticlopidine. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: German Heart Foundation.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Mount Sinai Fuster Heart Hospital, Icahn School of Medicine at Mount Sinai, New York, New York, USA; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy.
- Mount Sinai Fuster Heart Hospital, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
- Mount Sinai Fuster Heart Hospital, Icahn School of Medicine at Mount Sinai, New York, New York, USA; Department of Cardiology, University Heart & Vascular Centre Hamburg, University Medical Centre, Hamburg-Eppendorf, Ge…
- Mount Sinai Fuster Heart Hospital, Icahn School of Medicine at Mount Sinai, New York, New York, USA. Electronic address: roxana.mehran@mountsinai.org.
Förderung
- German Heart Foundation
Zitieren
APA
Gitto, M., Sartori, S., Vogel, B., Leone, P. P., Smith, K., Bay, B., Krishnan, P., Sweeny, J., Oliva, A., Moreno, P., Gilhooley, S., Di Muro, F. M., Krishnamoorthy, P. M., Kini, A., Dangas, G., Mehran, R., & Sharma, S. (2025). Potent P2Y12 Inhibitors vs Clopidogrel in Cancer Patients Undergoing Percutaneous Coronary Intervention. Canadian Journal of Cardiology. https://doi.org/10.1016/j.cjca.2025.02.035
Vancouver
Gitto M, Sartori S, Vogel B, Leone PP, Smith K, Bay B, et al. Potent P2Y12 Inhibitors vs Clopidogrel in Cancer Patients Undergoing Percutaneous Coronary Intervention. Canadian Journal of Cardiology. 2025. doi:10.1016/j.cjca.2025.02.035
BibTeX
@article{Gitto2025,
author = {Gitto, Mauro and Sartori, Samantha and Vogel, Birgit and Leone, Pier Pasquale and Smith, Kenneth and Bay, Benjamin and Krishnan, Prakash and Sweeny, Joseph and Oliva, Angelo and Moreno, Pedro and Gilhooley, Sean and Di Muro, Francesca Maria and Krishnamoorthy, Parasuram Melarcode and Kini, Annapoorna and Dangas, George and Mehran, Roxana and Sharma, Samin},
title = {Potent P2Y12 Inhibitors vs Clopidogrel in Cancer Patients Undergoing Percutaneous Coronary Intervention},
journal = {Canadian Journal of Cardiology},
year = {2025},
doi = {10.1016/j.cjca.2025.02.035}
}
EUVIMED